CIK 0001699382 · Non-accelerated filer<br>Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463218129
- Phone
- (609) 642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-01 | Schroeder Thilo Director | Sale | −11,541 | $30.10 | $347K | 1,102,183 |
| 2021-09-30 | Schroeder Thilo Director | Sale | −2,978 | $30.03 | $89K | 1,113,724 |
| 2021-09-29 | Schroeder Thilo Director | Sale | −5,708 | $30.04 | $171K | 1,116,702 |
| 2021-09-27 | Schroeder Thilo Director | Sale | −1,753 | $30.11 | $53K | 1,122,410 |
| 2021-09-22 | Schroeder Thilo Director | Sale | −100 | $30.00 | $3K | 1,124,163 |
| 2021-09-22 | LEVINE ARNOLD J Director | Sale | −3,500 | $30.00 | $105K | 409,842 |
| 2021-09-17 | Schroeder Thilo Director | Sale | −711 | $30.03 | $21K | 1,124,263 |
| 2021-09-13 | Schroeder Thilo Director | Sale | −13,272 | $30.20 | $401K | 1,124,974 |
| 2021-09-10 | Schroeder Thilo Director | Sale | −38,056 | $30.44 | $1.2M | 1,143,417 |
| 2021-09-10 | Schroeder Thilo Director | Sale | −5,171 | $31.03 | $160K | 1,138,246 |
| 2021-09-09 | Schroeder Thilo Director | Sale | −14,329 | $30.31 | $434K | 1,181,473 |
| 2021-09-09 | Alland Leila Chief Medical Officer | Option exercise | +100 | $3.90 | $390 | 100 |
| 2021-09-09 | Alland Leila Chief Medical Officer | Sale | −100 | $30.25 | $3K | 0 |
| 2021-09-09 | Alland Leila Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −100 | 353,850 | ||
| 2021-09-07 | Alland Leila Chief Medical Officer | Option exercise | +3,900 | $3.90 | $15K | 3,900 |
| 2021-09-07 | Alland Leila Chief Medical Officer | Sale | −3,900 | $30.25 | $118K | 0 |
| 2021-09-07 | Alland Leila Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −3,900 | 353,950 | ||
| 2021-09-02 | Schroeder Thilo Director | Sale | −5,400 | $30.15 | $163K | 1,195,802 |
| 2021-09-01 | Schroeder Thilo Director | Sale | −21,986 | $30.38 | $668K | 1,201,202 |
| 2021-08-31 | Schroeder Thilo Director | Sale | −19,520 | $30.12 | $588K | 1,223,188 |
Page 7 of 10 · 196 trades